{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:44:11Z","timestamp":1793835851448,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences & Peking Union Medical College","doi-asserted-by":"publisher","award":["2021-I2M-5-005"],"award-info":[{"award-number":["2021-I2M-5-005"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128150","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T21:56:41Z","timestamp":1766786201000},"page":"128150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A single ultra-low dose self-amplifying RNA rabies vaccine confers rapid and complete protection in mice"],"prefix":"10.1016","volume":"73","author":[{"given":"Danhua","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"XuelianWang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouchun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6592","key":"10.1016\/j.vaccine.2025.128150_bb0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.abn0713","article-title":"Rabies shows how scale of transmission can enable acute infections to persist at low prevalence","volume":"376","author":"Mancy","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2025.128150_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.prevetmed.2020.105161","article-title":"Regional and age difference of human rabies prevalence of the past fourteen years in China","volume":"187","author":"Qiao","year":"2021","journal-title":"Prev Vet Med"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128150_bb0015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40249-023-01082-3","article-title":"Progress towards dog-mediated rabies elimination in PR China: a scoping review","volume":"12","author":"Shen","year":"2023","journal-title":"Infect Dis Poverty"},{"issue":"9951","key":"10.1016\/j.vaccine.2025.128150_bb0020","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","article-title":"Current status of rabies and prospects for elimination","volume":"384","author":"Fooks","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2025.128150_bb0025","doi-asserted-by":"crossref","first-page":"17091","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128150_bb0030","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1474-4422(13)70038-3","article-title":"Human rabies: neuropathogenesis, diagnosis, and management","volume":"12","author":"Hemachudha","year":"2013","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128150_bb0035","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ymthe.2024.12.055","article-title":"Alphaviral backbone of self-amplifying RNA enhances protein expression and immunogenicity against SARS-CoV-2 antigen","volume":"33","author":"Casmil","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.128150_bb0040","unstructured":"<Zero_by_30_FINAL_online_version.pdf>."},{"issue":"4","key":"10.1016\/j.vaccine.2025.128150_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128150_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001388","article-title":"The blueprint for rabies prevention and control: a novel operational toolkit for rabies elimination","volume":"6","author":"Lembo","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2025.128150_bb0055","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/QCO.0000000000000578","article-title":"WHO'S new rabies recommendations: implications for high incidence countries","volume":"32","author":"Pattanaik","year":"2019","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128150_bb0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.biologicals.2009.02.015","article-title":"Issues associated with residual cell-substrate DNA in viral vaccines","volume":"37","author":"Sheng-Fowler","year":"2009","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2025.128150_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2023.101992","article-title":"Canine rabies: an epidemiological significance, pathogenesis, diagnosis, prevention, and public health issues","volume":"97","author":"Kumar","year":"2023","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128150_bb0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0092-1157(84)80019-0","article-title":"A new inactivated tissue culture rabies vaccine for use in man. Evaluation of PCEC-vaccine by laboratory tests","volume":"12","author":"Barth","year":"1984","journal-title":"J Biol Stand"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128150_bb0075","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.vaccine.2009.09.090","article-title":"A comparative study on the safety and immunogenicity of purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab)","volume":"28","author":"Ashwathnarayana","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128150_bb0080","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1084\/jem.145.6.1617","article-title":"Suppression of cell-mediated immunity by street rabies virus","volume":"145","author":"Wiktor","year":"1977","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.128150_bb0085","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ymthe.2024.12.041","article-title":"A nucleoside-modified rabies mRNA vaccine induces long-lasting and comprehensive immune responses in mice and non-human primates","volume":"33","author":"Wang","year":"2025","journal-title":"Mol Ther"},{"issue":"8","key":"10.1016\/j.vaccine.2025.128150_bb0090","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.vaccine.2020.12.070","article-title":"Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: a phase 1 trial","volume":"39","author":"Aldrich","year":"2021","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2025.128150_bb0095","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2025.128150_bb0100","article-title":"An mRNA vaccine against rabies provides strong and durable protection in mice","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128150_bb0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41541-024-00925-w","article-title":"Safety and efficacy assessment of an mRNA rabies vaccine in dogs, rodents, and cynomolgus macaques","volume":"9","author":"Li","year":"2024","journal-title":"npj Vaccines"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2025.128150_bb0110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.virol.2013.07.021","article-title":"Engineered alphavirus replicon vaccines based on known attenuated viral mutants show limited effects on immunogenicity","volume":"447","author":"Maruggi","year":"2013","journal-title":"Virology"},{"issue":"48","key":"10.1016\/j.vaccine.2025.128150_bb0115","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1016\/j.vaccine.2023.10.019","article-title":"Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice","volume":"41","author":"Hongtu","year":"2023","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128150_bb0120","first-page":"51","article-title":"Epidemiology of rabies and current US vaccine guidelines","volume":"103","author":"Liu","year":"2020","journal-title":"R I Med J (2013)"},{"key":"10.1016\/j.vaccine.2025.128150_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113900","article-title":"Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: getting the message across","volume":"176","author":"Minnaert","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128150_bb0130","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.ymthe.2025.03.060","article-title":"The advent of clinical self-amplifying RNA vaccines","volume":"33","author":"Casmil","year":"2025","journal-title":"Mol Ther"},{"issue":"10","key":"10.1016\/j.vaccine.2025.128150_bb0135","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.4049\/jimmunol.1601877","article-title":"Induction of an IFN-mediated antiviral response by a self-amplifying RNA vaccine: implications for vaccine design","volume":"198","author":"Pepini","year":"2017","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2025.128150_bb0140","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02342-18","article-title":"Increasing the capping efficiency of the Sindbis virus nsP1 protein negatively affects viral infection","volume":"9","author":"LaPointe","year":"2018","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128150_bb0145","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/s41467-025-55843-9","article-title":"Safety and immunogenicity of an optimized self-replicating RNA platform for low dose or single dose vaccine applications: a randomized, open label phase I study in healthy volunteers","volume":"16","author":"Maine","year":"2025","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128150_bb0150","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1038\/s41467-023-39421-5","article-title":"Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses","volume":"14","author":"Hellgren","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128150_bb0155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12985-022-01919-7","article-title":"An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs","volume":"19","author":"Li","year":"2022","journal-title":"Virol J"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128150_bb0160","first-page":"262","article-title":"Research progress on neutralizing epitopes and antibodies for the rabies virus","volume":"1","author":"Shi","year":"2022","journal-title":"Inf Med"},{"issue":"38","key":"10.1016\/j.vaccine.2025.128150_bb0165","article-title":"Divergent delivery and expression kinetics of lipid and polymeric nanoparticles across mRNA modalities","volume":"12","author":"Casmil","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"4","key":"10.1016\/j.vaccine.2025.128150_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/v17040566","article-title":"Self-amplifying RNA: advantages and challenges of a versatile platform for vaccine development","volume":"17","author":"Vallet","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.128150_bb0175","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.omtn.2022.11.024","article-title":"Formulation, inflammation, and RNA sensing impact the immunogenicity of self-amplifying RNA vaccines","volume":"31","author":"Tregoning","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"10.1016\/j.vaccine.2025.128150_bb0180","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1038\/s41467-024-47905-1","article-title":"Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials","volume":"15","author":"H\u1ed3","year":"2024","journal-title":"Nat Commun"},{"issue":"18","key":"10.1016\/j.vaccine.2025.128150_bb0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26188986","article-title":"The interplay between therapeutic self-amplifying RNA and the innate immune system: balancing efficiency and reactogenicity","volume":"26","author":"Kunyk","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2025.128150_bb0190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jconrel.2022.11.022","article-title":"Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccines","volume":"353","author":"Kim","year":"2023","journal-title":"J Control Release"},{"issue":"3","key":"10.1016\/j.vaccine.2025.128150_bb0195","article-title":"Self-amplifying RNA: a second revolution of mRNA vaccines against COVID-19","volume":"12","author":"Silva-Pilipich","year":"2024","journal-title":"Vaccines (Basel)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:04:46Z","timestamp":1770282286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":39,"alternative-id":["S0264410X25014483"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128150","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A single ultra-low dose self-amplifying RNA rabies vaccine confers rapid and complete protection in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128150"}}